Clene (CLNN) Minority Interest (2021 - 2022)

Clene (CLNN) posted Minority Interest of $1.7 million for Q3 2022, down 54.05% on a QoQ basis from $3.7 million in Q2 2022.

Analysis

Clene (CLNN) Minority Interest (2021 - 2022) Analysis & Trends

Clene has reported Minority Interest for 2 years, with the latest figure at $1.7 million in Q3 2022.

On a quarterly basis, Minority Interest changed N/A year-over-year to $1.7 million in Q3 2022; TTM through Sep 2022 was $1.7 million, a N/A change from a year earlier, with the FY2021 full-year figure at $600000.0, changed N/A from the prior year.
Minority Interest was $1.7 million for Q3 2022 at Clene, down from $3.7 million in the prior quarter.
The five-year high for Minority Interest was $3.7 million in Q2 2022, with the low at $600000.0 in Q4 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Johnson & Johnson	641.14 Bn	620.38 Bn	17.26 Bn
2	AbbVie	451.04 Bn	444.47 Bn	12.70 Bn
3	Merck	357.43 Bn	350.29 Bn	12.21 Bn
4	Novartis Ag	266.73 Bn	259.04 Bn	11.24 Bn
5	Pfizer	157.52 Bn	145.82 Bn	10.94 Bn
6	Sanofi	52.14 Bn	44.76 Bn	10.79 Bn
7	Revolution Medicines	42.88 Bn	42.88 Bn	-
8	Incyte	24.70 Bn	20.16 Bn	1.57 Bn
9	United Therapeutics	21.47 Bn	18.80 Bn	683.80 Mn
10	Clene	45.69 Mn	45.69 Mn	54,000.00

Historic Data

Download Data